ICAM1 and metabolic disease: Exercise-induced MECP2K271la may attenuate atherosclerosis in patients with metabolic disorders by suppressing vascular adhesion molecules (e.g., ICAM-1) and promoting anti-inflammatory pathways (Table 2).